Related Experiment Videos
A preliminary study of microcapsule suspension for hemolysis evaluation of artificial organs
O Maruyama1, T Yamane, N Tsunemoto
1Mechanical Engineering Laboratory, University of Tsukuba, Japan. maru@mel.go.jp
Abstract:
A microcapsule suspension, a substitute for animal blood in hemolysis tests, has been developed for evaluation of the absolute hemolytic properties of circulatory artificial organs. The microcapsule suspension was made by dispersing microcapsule slurry into an ethylene glycol sodium chloride solution. The microcapsule slurry was composed of a leuco dye solution and polyurethane membrane made by the reaction between aliphatic poly-isocyanate and polyamine by interfacial polycondensation. The microcapsule was a small particle containing dye inside. The microcapsule suspension was white; the diameter of the microcapsules was from 5 to 100 microns. The specific gravity of the suspension was 1.024, and the membrane was elastic. The fluid showed Newtonian characteristics, different from animal blood, and its viscosity was approximately 5.8 mPa.s. After the microcapsules were destroyed, the leuco dye was extracted with n-hexane from the suspension and was measured by spectroscopy after being colored with acid ethanol. Hemolysis can be regarded as a fatigue fracture of cell membranes rather than a static fracture. The destruction of microcapsules by a Potter type tissue grinder was observed at a low stroke number region and was compared to rat blood. Moreover, hemolysis tests of a commercially available centrifugal blood pump and the prototype of our centrifugal pump for mechanism checks were carried out with bovine blood. The hemolysis level of the prototype pump increased with time while the hemolysis level of the commercial blood pump did not change as much as that of the control when both pumps were tested with the microcapsule suspension. These results are similar to tests utilizing bovine blood. Therefore, hemolysis tests of circulatory artificial organs completed with microcapsule suspension are expected to provide results similar to tests with animal blood.
Insights
A novel microcapsule suspension offers a viable alternative to animal blood for hemolysis testing of artificial organs. This blood substitute demonstrates similar results to animal blood, aiding in the evaluation of circulatory device performance.
Area of Science:
- Biomaterials Science
- Medical Device Engineering
- Hemolysis Testing
Background:
- Hemolysis testing is crucial for evaluating the biocompatibility of circulatory artificial organs.
- Animal blood is traditionally used, but ethical and practical concerns exist.
- A reliable blood substitute is needed for consistent and ethical hemolysis evaluation.
Purpose of the Study:
- To develop and evaluate a microcapsule suspension as a substitute for animal blood in hemolysis tests.
- To assess the hemolytic properties of circulatory artificial organs using the developed microcapsule suspension.
- To compare the performance of the microcapsule suspension with animal blood in hemolysis tests.
Main Methods:
- A microcapsule suspension was prepared using polyurethane membranes encapsulating a leuco dye.
- The microcapsules were dispersed in an ethylene glycol sodium chloride solution.
- Hemolysis was assessed by measuring leuco dye release after microcapsule destruction and comparing pump performance with bovine blood.
Main Results:
- The microcapsule suspension exhibited Newtonian fluid characteristics with a viscosity of approximately 5.8 mPa.s.
- Microcapsule destruction patterns correlated with hemolysis mechanisms observed in biological membranes.
- Tests with centrifugal blood pumps showed comparable results to those using bovine blood, indicating the suspension's efficacy.
Conclusions:
- The developed microcapsule suspension serves as a promising alternative to animal blood for hemolysis testing.
- This blood substitute enables accurate evaluation of circulatory artificial organ performance.
- The microcapsule suspension provides results similar to animal blood, supporting its use in device development.